Our findings further suggests that upregulation of astrocytic apoE expression and or its lipidation can be of therapeutic benefit in prion disease through enhancing phagocytic characteristics of activated microglia and promoting clearance of neuronal debris and PrPSc. Here, APOE is linked to prion disease.